by Elana Gotkine Credit: Pixabay/CC0 Public Domain In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31 in Schizophrenia Bulletin. Dongyu Kang, M.D., from The Second Xiangya Hospital of Central South University in Changsha, China, and colleagues conducted a double-blind, randomized trial...
Tag: <span>New treatment</span>
First New Treatment in 30 Years for Rare Disease Effective, Tolerable, Convenient
Nancy A. Melville PHOENIX — Subcutaneous efgartigimod PH20 SC shows efficacy and tolerability in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), providing a convenient alternative to intravenous and other older treatments for this rare disease. “This was the largest study of CIDP that has been performed, with over 600 patients screened and 322 enrolled,...
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
by University of Chicago Medical Center Credit: Cell Reports Medicine (2023). DOI: 10.1016/j.xcrm.2023.101261 Type 1 diabetes is an autoimmune disease that causes the body’s immune system to attack and destroy insulin-producing beta cells in the pancreas. Traditional management of type 1 diabetes has primarily involved replacing the missing insulin with injections which, though effective, can be...
Surgery-free brain stimulation could provide new treatment for dementia
by Ryan O’Hare, Imperial College London Temporal interference (TI) is non-invasive and delivers electrical stimulation through electrodes placed on the participant’s head. Credit: Imperial College LondonScientists at Imperial College London are leading on the development and testing of the new method of stimulating the brain, which could provide an alternative treatment for brain diseases such as...
Clinical trial studying possible new treatment option for patients with NAFLD
UNIVERSITY OF CALIFORNIA – SAN DIEGO IMAGE: MOST OF THE RESEARCH INVOLVED IN THE SAMARA STUDY WILL TAKE PLACE AT THE ALTMAN CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTE, PICTURED ABOVE, LOCATED AT JACOBS MEDICAL CENTER AT UC SAN DIEGO HEALTH. view more CREDIT: UC SAN DIEGO HEALTH According to the National Institutes of Health, approximately 24%...
Clinical trial identifies potential new treatment for liver disease
by University of California – San Diego Credit: Pixabay/CC0 Public Domain Researchers at the University of California San Diego School of Medicine have led a study to examine a potential new treatment option for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis. The results, published in the June 24, 2023, online edition of The New England Journal of Medicine, found...
Researchers identify potential new treatment for those who act out their dreams while sleeping
by The Mount Sinai Hospital Credit: Unsplash/CC0 Public Domain Mount Sinai researchers have published what they say is the first study to identify a new form of treatment for rapid eye movement (REM) sleep behavior disorder. This condition affects more than 3 million Americans, mostly adults over the age of 50, who often unknowingly physically act out their...
Insight into tumor cells’ organanization offers hope for new treatment
By Bronwyn Thompson March 16, 2023 Scientists map out mitochondrial structures in lung cancer tumors to find complex, nutrient-specific needs of the cells Depositphotos.com It’s well known that the engine room of cells, the mitochondria, have a key role in fueling cancer growth. Treatments have targeted these microscopic organelles in many ways, including by blocking their...
New treatment approach for prostate cancer could stop resistance in its tracks
by Sanford Burnham Prebys Medical Discovery Institute Prostate cancer cells. Credit: NIH Image Gallery For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα. The findings, published recently in Science Advances, could help address the growing threat of treatment resistance in prostate cancer and could also lead to...
Blood cancer research points to new treatment for bone marrow cancer
by University of Virginia Deletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells. a A scheme on competitive BM transplantation approach to assess the effects of IL-1R1 deletion on Jak2V617F mutant hematopoietic stem/progenitors is depicted. b Percentages of donor-derived (CD45.2+) total, myeloid cells (Gr1+), B cells (B220+), and T cells (TCRβ+) in peripheral blood were measured every 4...